系统性红斑狼患者的氧化:多少足够?
Guillermo Ruiz-Irastorza1,2, Diana Paredes-Ruiz3, Fernando Arizpe3,4
1Autoimmune Diseases, Biobizkaia Health Research Institute, Barakaldo, Bizkaia, Spain guillermo.ruiz@ehu.eus.
Lupus science & medicine
|February 26, 2025
概括
在每天200毫克 (3.0-3.5毫克/公斤/天) 的稳定剂量下,氧化 (HCQ) 对于系统性红斑狼的长期缓解是有效的. 大多数患者通过HCQ作为背景治疗实现了长期缓解.
科学领域:
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 系统性红斑狼 (SLE) 管理通常涉及氧化 (HCQ).
- 优化HCQ剂量对于实现和维持长期缓解至关重要.
- 了解HCQ剂量与缓解之间的关系对于患者的治疗结果至关重要.
研究的目的:
- 评估每日和体重调整的氧化 (HCQ) 剂量对SLE患者长期缓解的影响.
- 分析HCQ剂量与5年持续缓解之间的关联.
- 调查HCQ剂量与使用普得尼松或其他免疫抑制剂之间的潜在相关性.
主要方法:
- 观察性研究,使用来自狼-克鲁塞斯队列的常规临床护理数据.
- 包括开始接受HCQ治疗的患者,随访时间至少为5年.
- 长期缓解的定义基于使用SLE缓解标准的连续年度评估.
主要成果:
- 150名患者符合纳入标准;98%在整个5年随访期间保持HCQ治疗.
- 72%的患者实现了长期缓解.
- 在实现缓解和未实现缓解的患者之间,没有观察到平均体重调整后的HCQ剂量的显著差异.
结论:
- 稳定的HCQ剂量为200mg/天 (大约3.0-3.5mg/kg/天) 与大多数SLE患者的长期缓解有关.
- 在SLE中,HCQ作为有效的背景治疗来维持缓解.
- HCQ的剂量似乎没有受到同时使用普得尼松,免疫抑制剂或美巴克林的影响.
相关概念视频
Renal Failure: Dose Adjustments
54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.8K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.8K
Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
Antihypertensive Drugs: Thiazide-Class Diuretics
515
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
515


